Suppr超能文献

足月引产时阴道和舌下含服米索前列醇患者满意度的随机对照比较。

A randomised comparison of patient satisfaction with vaginal and sublingual misoprostol for induction of labour at term.

作者信息

Nassar A H, Awwad J, Khalil A M, Abu-Musa A, Mehio G, Usta I M

机构信息

Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

BJOG. 2007 Oct;114(10):1215-21. doi: 10.1111/j.1471-0528.2007.01492.x.

Abstract

OBJECTIVE

To compare patient satisfaction with two routes of misoprostol for term labour induction.

DESIGN

Prospective randomised trial.

SETTING

Tertiary care hospital.

POPULATION

A total of 170 women admitted at > or = 37 weeks of gestation for induction of labour.

METHODS

Women were randomised to receive 50 micrograms of either sublingual or vaginal misoprostol.

MAIN OUTCOME MEASURES

Patient satisfaction with the route of administration.

RESULTS

Despite a similar proportion reporting the labour induction as more painful than expected in both groups, a significantly lower proportion mentioned that the pelvic examinations were very painful in the sublingual group (19.7 versus 36.1%, relative risk [RR] 0.5, 95% CI 0.3-0.9). Request for analgesia was similar in both groups. More women in the sublingual group thought that the labour experience was better than expected (RR 2.0, 95% CI 1.2-3.3), had a positive attitude towards induction in subsequent pregnancies (RR 1.6, 95% CI 1.1-2.3) and preferred the same route in subsequent pregnancies (RR 3.1, 95% CI 2.2-4.5). Mean number of misoprostol doses, oxytocin augmentation, tachysystole and hyperstimulation, induction to vaginal delivery interval, vaginal delivery after a single dose, vaginal birth within 12 and 24 hours, and caesarean delivery rates were similar in both groups.

CONCLUSION

Sublingual misoprostol (50 micrograms) is associated with a significantly higher patient satisfaction rate compared with a similar dose of vaginal misoprostol. Sublingual administration offers additional choice to women, in particular those wishing to avoid vaginal administration.

摘要

目的

比较米索前列醇两种给药途径用于足月引产时患者的满意度。

设计

前瞻性随机试验。

地点

三级护理医院。

研究对象

共170例妊娠≥37周入院引产的妇女。

方法

将妇女随机分为接受50微克舌下含服或阴道用米索前列醇两组。

主要观察指标

患者对给药途径的满意度。

结果

尽管两组中报告引产比预期更疼痛的比例相似,但舌下含服组提及盆腔检查非常疼痛的比例显著更低(19.7%对36.1%,相对危险度[RR]0.5,95%可信区间0.3 - 0.9)。两组的镇痛需求相似。舌下含服组更多妇女认为引产经历比预期更好(RR 2.0,95%可信区间1.2 - 3.3),对后续妊娠引产持积极态度(RR 1.6,95%可信区间1.1 - 2.3),且在后续妊娠中更倾向于相同给药途径(RR 3.1,95%可信区间2.2 - 4.5)。两组米索前列醇平均剂量、缩宫素加强使用、宫缩过速和子宫过度刺激、引产至阴道分娩间隔时间、单剂量后阴道分娩、12小时和24小时内阴道分娩以及剖宫产率相似。

结论

与相同剂量的阴道用米索前列醇相比,舌下含服米索前列醇(50微克)患者满意度显著更高。舌下含服给药为妇女提供了额外选择,尤其是那些希望避免阴道给药的妇女。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验